Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASCAT A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. 24292274

2014

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASDB A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. 24292274

2014

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASCAT Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. 23770605

2013

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASDB Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. 23770605

2013

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASDB Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. 22700719

2012

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASCAT Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. 22700719

2012

dbSNP: rs872071
rs872071
0.840 GeneticVariation BEFREE A recent genome wide association study of chronic lymphocytic leukaemia (CLL) provided evidence that common variation at 2q13 (rs17483466), 2q37.1 (rs13397985), 6p25.3 (rs872071), 11q24.1 (rs735665), 15q23 (rs7176508) and 19q13.32 (rs11083846) affects CLL risk. 20553269

2010

dbSNP: rs872071
rs872071
0.840 GeneticVariation BEFREE Common single nucleotide polymorphisms (SNPs) at 2q13 (rs17483466), 2q37.1 (rs13397985), 2q37.3 (rs757978), 6p25.3 (rs872071), 8q24.21 (rs2456449), 11q24.1 (rs735665), 15q21.3 (rs7169431), 15q23 (rs7176508), 16q24.1 (rs305061), and 19q13.32 (rs11083846) have been shown to confer a modest but significant increase in CLL risk. 20855867

2010

dbSNP: rs872071
rs872071
0.840 GeneticVariation BEFREE We have recently shown that the IRF4 variant rs872071 influences CLL risk. 19804451

2010

dbSNP: rs872071
rs872071
0.840 GeneticVariation BEFREE We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASCAT We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008

dbSNP: rs872071
rs872071
G 0.840 GeneticVariation GWASDB We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). 18758461

2008